Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Gynecologie, Obstetrique & Fertilite|October 6, 2007
[Increased risk of relapse in multiple sclerosis patients after ovarian stimulation for in vitro fertilization]D-A Laplaud, F Lefrère, E Leray, et al.La Revue De Medecine Interne|April 30, 2013
[Adaptative immunity and pathophysiology of multiple sclerosis]M Salou, A Elong Ngono, A Garcia, et al.Journal of Neurology, Neurosurgery, and Psychiatry|May 25, 2013
Mycophenolate mofetil in multiple sclerosis: a multicentre retrospective study on 344 patientsL Michel, S Vukusic, J De Seze, et al.Revue Neurologique|October 2, 2021
Cost-utility of oral methylprednisolone in the treatment of multiple sclerosis relapses: Results from the COPOUSEP trialM Michel, E Le Page, D A Laplaud, et al.Journal of Neurology|September 9, 2020
SMILE: a predictive model for Scoring the severity of relapses in MultIple scLErosisF Lejeune, A Chatton, D-A Laplaud, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 21, 2013
Unique B cell differentiation profile in tolerant kidney transplant patientsM Chesneau, A Pallier, F Braza, et al.Clinical Immunology (Orlando, Fla.)|May 17, 2017
Decrease of blood anti-α1,3 Galactose Abs levels in multiple sclerosis (MS) and clinically isolated syndrome (CIS) patientsL Le Berre, J Rousse, P-A Gourraud, et al.Journal of Neurology|July 29, 2018
Inaugural tumor-like multiple sclerosis: clinical presentation and medium-term outcome in 87 patientsG Balloy, J Pelletier, L Suchet, et al.BMC Medical Research Methodology|May 31, 2022
Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosisM Lefort, S Sharmin, J B Andersen, et al.Pageof 1